A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic ...

A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. A new blood test that ...

A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...

A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.

For the first time in 30 years, the Food and Drug Administration has approved a new treatment for an inoperable type of pancreatic cancer​.

ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced the launch of its enhanced Avantect(R) Pancreatic Cancer Test, which delivers ...

We retrospectively analyzed 191 patients who received systemic chemotherapy for advanced or metastatic pancreatic cancer at Gangneung Asan Hospital and the Asan Medical Center between 2014 and 2023.

Cedars Sinai tool predicts the best chemotherapy regimen for advanced pancreatic cancer using AI analysis of biopsy images.

HIGHLIGHTSAmplia’s lead drug narmafotinib enhances the activity of kRAS inhibitors in multiple preclinical cancer models presented at US ...

Now, a Carnegie Mellon University spinout company aims to identify patients at high risk for lung, liver and pancreatic ...

Researchers at Academia Sinica and National Taiwan University Hospital have developed an AI-powered blood test that detects early-stage pancreatic cancer with near-perfect accuracy in validation ...